Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.
2.

Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose.

Pettie JM, Caparrotta TM, Hunter RW, Morrison EE, Wood DM, Dargan PI, Thanacoody RH, Thomas SHL, Elamin MEMO, Francis B, Webb DJ, Sandilands EA, Eddleston M, Dear JW.

EClinicalMedicine. 2019 May 2;11:11-17. doi: 10.1016/j.eclinm.2019.04.005. eCollection 2019 May-Jun.

3.

Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.

Nashabat M, Obaid A, Al Mutairi F, Saleh M, Elamin M, Ahmed H, Ababneh F, Eyaid W, Alswaid A, Alohali L, Faqeih E, Aljeraisy M, Hussein MA, Alasmari A, Alfadhel M.

BMC Pediatr. 2019 Jun 13;19(1):195. doi: 10.1186/s12887-019-1571-y.

4.

Ketogenic Diet Modulates NAD+-Dependent Enzymes and Reduces DNA Damage in Hippocampus.

Elamin M, Ruskin DN, Masino SA, Sacchetti P.

Front Cell Neurosci. 2018 Aug 30;12:263. doi: 10.3389/fncel.2018.00263. eCollection 2018.

5.

Erratum. Aspirin for the Primary Prevention of Cardiovascular Events. A Systematic Review and Meta-Analysis Comparing Patients With and Without Diabetes. Diabetes Care 2009;32:2300-2306.

Calvin AD, Aggarwal NR, Murad MH, Shi Q, Elamin MB, Geske JB, Fernandez-Balsells MM, Albuquerque FN, Lampropulos JF, Erwin PJ, Smith SA, Montori VM.

Diabetes Care. 2018 Jun;41(6):1321-1322. doi: 10.2337/dc18-er06a. Epub 2018 Apr 23. No abstract available.

6.

ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.

Daghestani M, Daghestani M, Daghistani M, Eldali A, Hassan ZK, Elamin MH, Warsy A.

Lipids Health Dis. 2018 Mar 27;17(1):58. doi: 10.1186/s12944-018-0679-7.

7.

LC-MS/MS Tandem Mass Spectrometry for Analysis of Phenolic Compounds and Pentacyclic Triterpenes in Antifungal Extracts of Terminalia brownii (Fresen).

Salih EYA, Fyhrquist P, Abdalla AMA, Abdelgadir AY, Kanninen M, Sipi M, Luukkanen O, Fahmi MKM, Elamin MH, Ali HA.

Antibiotics (Basel). 2017 Dec 13;6(4). pii: E37. doi: 10.3390/antibiotics6040037.

8.

Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?

Elamin M, Ruskin DN, Masino SA, Sacchetti P.

Front Mol Neurosci. 2017 Nov 14;10:377. doi: 10.3389/fnmol.2017.00377. eCollection 2017.

9.

Reductions in emergency department visits after primary healthcare use of the UK National Poisons Information Service.

Elamin MEMO, James DA, Holmes P, Jackson G, Thompson JP, Sandilands EA, Bradberry S, Thomas SHL.

Clin Toxicol (Phila). 2018 May;56(5):342-347. doi: 10.1080/15563650.2017.1390120. Epub 2017 Oct 26.

PMID:
29069928
10.

Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis.

O'Brien M, Burke T, Heverin M, Vajda A, McLaughlin R, Gibbons J, Byrne S, Pinto-Grau M, Elamin M, Pender N, Hardiman O.

JAMA Neurol. 2017 Dec 1;74(12):1425-1430. doi: 10.1001/jamaneurol.2017.2699.

11.

Molecular and clinical spectra of FBXL4 deficiency.

El-Hattab AW, Dai H, Almannai M, Wang J, Faqeih EA, Al Asmari A, Saleh MAM, Elamin MAO, Alfadhel M, Alkuraya FS, Hashem M, Aldosary MS, Almass R, Almutairi FB, Alsagob M, Al-Owain M, Al-Sharfa S, Al-Hassnan ZN, Rahbeeni Z, Al-Muhaizea MA, Makhseed N, Foskett GK, Stevenson DA, Gomez-Ospina N, Lee C, Boles RG, Schrier Vergano SA, Wortmann SB, Sperl W, Opladen T, Hoffmann GF, Hempel M, Prokisch H, Alhaddad B, Mayr JA, Chan W, Kaya N, Wong LC.

Hum Mutat. 2017 Dec;38(12):1649-1659. doi: 10.1002/humu.23341. Epub 2017 Oct 6. Review.

PMID:
28940506
12.

Synergistic Anti-Breast-Cancer Effects of Combined Treatment With Oleuropein and Doxorubicin In Vivo.

Elamin MH, Elmahi AB, Daghestani MH, Al-Olayan EM, Al-Ajmi RA, Alkhuriji AF, Hamed SS, Elkhadragy MF.

Altern Ther Health Med. 2019 May;25(3):17-24.

PMID:
28646810
13.

Assessing behavioural changes in ALS: cross-validation of ALS-specific measures.

Pinto-Grau M, Costello E, O'Connor S, Elamin M, Burke T, Heverin M, Pender N, Hardiman O.

J Neurol. 2017 Jul;264(7):1397-1401. doi: 10.1007/s00415-017-8536-6. Epub 2017 Jun 9.

PMID:
28600595
14.

Semi-quantitative analysis of cerebral FDG-PET reveals striatal hypermetabolism and normal cortical metabolism in a case of VGKCC limbic encephalitis.

Moloney P, Boylan R, Elamin M, O'Riordan S, Killeen R, McGuigan C.

Neuroradiol J. 2017 Apr;30(2):160-163. doi: 10.1177/1971400916689578. Epub 2017 Jan 1.

15.

Uncommon mutation in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS).

David J, Okiro JO, Murphy K, Elamin M.

BMJ Case Rep. 2017 Feb 27;2017. pii: bcr2016218133. doi: 10.1136/bcr-2016-218133.

16.

Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: executive function as a mediator, and predictor of performance.

Burke T, Lonergan K, Pinto-Grau M, Elamin M, Bede P, Madden C, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):193-201. doi: 10.1080/21678421.2016.1272615. Epub 2017 Jan 13.

PMID:
28084080
17.

Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data.

Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, Vajda A, Heverin M, Elamin M, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):99-106. doi: 10.1080/21678421.2016.1249887. Epub 2016 Nov 28.

PMID:
27894201
18.

Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI).

Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O'Sullivan M, Lonergan K, Kirby E, Quinlan E, Breen N, Vajda A, Heverin M, Pender N, Hardiman O.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):68-73. doi: 10.1080/21678421.2016.1248976. Epub 2016 Nov 28.

PMID:
27894191
19.

Prevalence and genotyping ofToxoplasma gondii among Saudi pregnant women in Saudi Arabia.

Alghamdi J, Elamin MH, Alhabib S.

Saudi Pharm J. 2016 Nov;24(6):645-651. Epub 2015 May 23.

20.

Schizophrenia: Impact of psychopathology, faith healers and psycho-education on adherence to medications.

Abdel Aziz K, Elamin MH, El-Saadouni NM, El-Gabry DA, Barakat M, Alhayyas F, Moselhy HF.

Int J Soc Psychiatry. 2016 Dec;62(8):719-725. Epub 2016 Nov 3.

PMID:
27815512
21.

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.

Wasunna M, Njenga S, Balasegaram M, Alexander N, Omollo R, Edwards T, Dorlo TP, Musa B, Ali MH, Elamin MY, Kirigi G, Juma R, Kip AE, Schoone GJ, Hailu A, Olobo J, Ellis S, Kimutai R, Wells S, Khalil EA, Strub Wourgaft N, Alves F, Musa A.

PLoS Negl Trop Dis. 2016 Sep 14;10(9):e0004880. doi: 10.1371/journal.pntd.0004880. eCollection 2016 Sep.

22.

Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study.

Burke T, Pinto-Grau M, Lonergan K, Elamin M, Bede P, Costello E, Hardiman O, Pender N.

PLoS One. 2016 Aug 24;11(8):e0160850. doi: 10.1371/journal.pone.0160850. eCollection 2016.

23.

Delays during the administration of acetylcysteine for the treatment of paracetamol overdose.

Bailey GP, Najafi J, Elamin ME, Waring WS, Thomas SH, Archer JR, Wood DM, Dargan PI.

Br J Clin Pharmacol. 2016 Nov;82(5):1358-1363. doi: 10.1111/bcp.13063. Epub 2016 Aug 10.

24.

The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration.

Schuster C, Elamin M, Hardiman O, Bede P.

Eur J Neurol. 2016 Aug;23(8):1361-71. doi: 10.1111/ene.13038. Epub 2016 May 21.

PMID:
27207250
25.

Discordant performance on the 'Reading the Mind in the Eyes' Test, based on disease onset in amyotrophic lateral sclerosis.

Burke T, Elamin M, Bede P, Pinto-Grau M, Lonergan K, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):467-472. Epub 2016 May 6.

PMID:
27152765
26.

Survival analysis of geospatial factors in the Irish ALS cohort.

Rooney J, Heverin M, Vajda A, Burke T, Galvin M, Tobin K, Elamin M, Staines A, Hardiman O.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):555-560. Epub 2016 May 4.

PMID:
27145090
27.

The selective anatomical vulnerability of ALS: 'disease-defining' and 'disease-defying' brain regions.

Bede P, Iyer PM, Schuster C, Elamin M, Mclaughlin RL, Kenna K, Hardiman O.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):561-570. Epub 2016 Apr 18.

PMID:
27087114
28.

Erratum to: Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors.

Burke T, Elamin M, Galvin M, Gallagher L, Hardiman O, Pender N.

J Neurol. 2015 Dec;262(12):2799. doi: 10.1007/s00415-015-7941-y. No abstract available.

PMID:
26566911
29.

The Utility of the Addenbrooke's Cognitive Examination Version Three in Early-Onset Dementia.

Elamin M, Holloway G, Bak TH, Pal S.

Dement Geriatr Cogn Disord. 2016;41(1-2):9-15. doi: 10.1159/000439248. Epub 2015 Oct 17.

PMID:
26473749
30.

Nonrevascularization-based treatments in patients with severe or critical limb ischemia.

Abu Dabrh AM, Steffen MW, Asi N, Undavalli C, Wang Z, Elamin MB, Conte MS, Murad MH.

J Vasc Surg. 2015 Nov;62(5):1330-9.e13. doi: 10.1016/j.jvs.2015.07.069. Epub 2015 Sep 26. Review.

31.

The natural history of untreated severe or critical limb ischemia.

Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, Conte MS, Murad MH.

J Vasc Surg. 2015 Dec;62(6):1642-51.e3. doi: 10.1016/j.jvs.2015.07.065. Epub 2015 Sep 26. Review.

32.

Bypass surgery versus endovascular interventions in severe or critical limb ischemia.

Abu Dabrh AM, Steffen MW, Asi N, Undavalli C, Wang Z, Elamin MB, Conte MS, Murad MH.

J Vasc Surg. 2016 Jan;63(1):244-53.e11. doi: 10.1016/j.jvs.2015.07.068. Epub 2015 Sep 11. Review.

33.

Functional Connectivity Changes in Resting-State EEG as Potential Biomarker for Amyotrophic Lateral Sclerosis.

Iyer PM, Egan C, Pinto-Grau M, Burke T, Elamin M, Nasseroleslami B, Pender N, Lalor EC, Hardiman O.

PLoS One. 2015 Jun 19;10(6):e0128682. doi: 10.1371/journal.pone.0128682. eCollection 2015.

34.

Posterior cortical and white matter changes on MRI in anti-AMPA receptor antibody encephalitis.

Elamin M, Lonergan R, Killeen RP, O'Riordan S, Tubridy N, McGuigan C.

Neurol Neuroimmunol Neuroinflamm. 2015 May 21;2(4):e118. doi: 10.1212/NXI.0000000000000118. eCollection 2015 Aug. No abstract available.

35.

Renal cell carcinoma in children: case report and literature review.

Abdellah A, Selma K, Elamin M, Asmae T, Lamia R, Abderrahmane M, Sanaa el M, Hanan E, Tayeb K, Noureddine B.

Pan Afr Med J. 2015 Jan 29;20:84. doi: 10.11604/pamj.2015.20.84.5791. eCollection 2015. Review.

36.

Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors.

Burke T, Elamin M, Galvin M, Hardiman O, Pender N.

J Neurol. 2015 Jun;262(6):1526-32. doi: 10.1007/s00415-015-7746-z. Epub 2015 Apr 23. Erratum in: J Neurol. 2015 Dec;262(12):2799.

PMID:
25904206
37.

Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm.

Elamin M, Bede P, Montuschi A, Pender N, Chio A, Hardiman O.

J Neurol. 2015 Jun;262(6):1447-54. doi: 10.1007/s00415-015-7731-6. Epub 2015 Apr 11.

38.

Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland.

Rooney J, Vajda A, Heverin M, Elamin M, Crampsie A, McLaughlin R, Staines A, Hardiman O.

Neurology. 2015 Apr 14;84(15):1537-44. doi: 10.1212/WNL.0000000000001477. Epub 2015 Mar 13.

PMID:
25770197
39.

Presymptomatic and longitudinal neuroimaging in neurodegeneration--from snapshots to motion picture: a systematic review.

Schuster C, Elamin M, Hardiman O, Bede P.

J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1089-96. doi: 10.1136/jnnp-2014-309888. Epub 2015 Jan 28. Review.

PMID:
25632156
40.

Serum magnesium, iron and ferritin levels in patients with diabetic retinopathy attending Makkah Eye Complex, Khartoum, Sudan.

Hamdan HZ, Nasser NM, Adam AM, Saleem MA, Elamin MI.

Biol Trace Elem Res. 2015 May;165(1):30-4. doi: 10.1007/s12011-015-0236-4. Epub 2015 Jan 24.

PMID:
25613583
41.

Second-generation Irish genome-wide association study for amyotrophic lateral sclerosis.

McLaughlin RL, Kenna KP, Vajda A, Bede P, Elamin M, Cronin S, Donaghy CG, Bradley DG, Hardiman O.

Neurobiol Aging. 2015 Feb;36(2):1221.e7-13. doi: 10.1016/j.neurobiolaging.2014.08.030. Epub 2014 Sep 6.

PMID:
25442119
42.

The effect of appendectomy in future tubal infertility and ectopic pregnancy: a systematic review and meta-analysis.

Elraiyah T, Hashim Y, Elamin M, Erwin PJ, Zarroug AE.

J Surg Res. 2014 Dec;192(2):368-374.e1. doi: 10.1016/j.jss.2014.08.017. Epub 2014 Aug 13. Review.

PMID:
25303785
43.

First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.

Kelly JA, Boyle NT, Cole N, Slator GR, Colivicchi MA, Stefanini C, Gobbo OL, Scalabrino GA, Ryan SM, Elamin M, Walsh C, Vajda A, Goggin MM, Campbell M, Mash DC, O'Mara SM, Brayden DJ, Callanan JJ, Tipton KF, Della Corte L, Hunter J, O'Boyle KM, Williams CH, Hardiman O.

Neuropharmacology. 2015 Feb;89:193-203. doi: 10.1016/j.neuropharm.2014.09.024. Epub 2014 Sep 30.

PMID:
25281210
44.

Impact of reducing the threshold for acetylcysteine treatment in acute paracetamol poisoning: the recent United Kingdom experience.

Bateman DN, Dear JW, Carroll R, Pettie J, Yamamoto T, Elamin ME, Peart L, Dow M, Coyle J, Gray A, Dargan PI, Wood DM, Eddleston M, Thomas SH.

Clin Toxicol (Phila). 2014 Sep-Oct;52(8):868-72. doi: 10.3109/15563650.2014.954125.

PMID:
25200454
45.

Leishmanicidal and apoptotic activities of oleuropein on Leishmania major.

Elamin MH, AL-Maliki SS.

Int J Clin Pharmacol Ther. 2014 Oct;52(10):880-8. doi: 10.5414/CP202102.

PMID:
25109414
46.

Patterns of cerebral and cerebellar white matter degeneration in ALS.

Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, Fagan A, Bradley DG, Hardiman O.

J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):468-70. doi: 10.1136/jnnp-2014-308172. Epub 2014 Jul 21. No abstract available.

47.

Genotyping of Toxoplasma gondii from Rats (Rattus rattus) in Riyadh, Saudi Arabia.

Elamin MH.

Korean J Parasitol. 2014 Jun;52(3):257-61. doi: 10.3347/kjp.2014.52.3.257. Epub 2014 Jun 26.

48.

Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment.

A AO, M MM, A HA, Elamin MY, Younis BM, E ME, Musa AM, Elhassan AM, G EA.

Ann Saudi Med. 2014 Mar-Apr;34(2):143-6. doi: 10.5144/0256-4947.2014.143.

49.

Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment.

Bateman DN, Carroll R, Pettie J, Yamamoto T, Elamin ME, Peart L, Dow M, Coyle J, Cranfield KR, Hook C, Sandilands EA, Veiraiah A, Webb D, Gray A, Dargan PI, Wood DM, Thomas SH, Dear JW, Eddleston M.

Br J Clin Pharmacol. 2014 Sep;78(3):610-8. doi: 10.1111/bcp.12362.

50.

Fecundity in ALS.

Byrne S, Heverin M, Bede P, Elamin M, Hardiman O.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):204-6. doi: 10.3109/21678421.2013.865237. Epub 2014 Jan 31. No abstract available.

PMID:
24479554

Supplemental Content

Loading ...
Support Center